A Phase 3 trial evaluating the efficacy, duration of effect, and safety of DaxibotulinumtoxinA for Injection in the treatment of cervical dystonia

被引：0
|
作者：
Jankovic, J.
Comella, C.
Hauser, R.
Patel, A.
Gross, T.
Rubio, R.
Vitarella, D.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
100
引用
收藏
页码：S43 / S44
页数：2
相关论文
共 50 条
  • [21] PHASE 3 PRISM CLINICAL TRIAL EVALUATING EFFICACY AND SAFETY OF PEGVALIASE FOR TREATMENT OF ADULTS WITH PHENYLKETONURIA
    Thomas, J.
    Levy, H.
    Amato, S.
    Vockley, G.
    Zori, R.
    Dimmock, D.
    Harding, C.
    Bilder, D.
    Weng, H. H.
    Olbertz, J.
    Merilainen, M.
    Jiang, J.
    Gupta, S.
    Gu, Z.
    Larimore, K.
    Northrup, H.
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (03) : 270 - 270
  • [22] Efficacy Remaining at Time of Requested Retreatment Following Botulinum Toxin Treatment for Cervical Dystonia: Potential for a New Treatment Paradigm with DaxibotulinumtoxinA
    Ellenbogen, A.
    Hauser, R.
    Patel, A.
    McAllister, P.
    Vitarella, D.
    Gross, T.
    Kazerooni, R.
    Gallagher, C.
    Hollander, D.
    MOVEMENT DISORDERS, 2024, 39 : S644 - S645
  • [23] Commentary on A Large, Open-Label, Phase 3 Safety Study of DaxibotulinumtoxinA for Injection in Glabellar Lines
    Hausauer, Amelia K.
    DERMATOLOGIC SURGERY, 2021, 47 (01) : 47 - 47
  • [24] Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: A randomized-controlled trial
    Poewe, Werner
    Burbaud, Pierre
    Castelnovo, Giovanni
    Jost, Wolfgang H.
    Ceballos-Baumann, Andres O.
    Banach, Marta
    Potulska-Chromik, Anna
    Ferreira, Joaquim J.
    Bihari, Katalin
    Ehler, Edvard
    Bares, Martin
    Dzyak, Lyudmyla A.
    Belova, Anna N.
    Pham, Emmanuel
    Liu, Wenzhong Jerry
    Picaut, Philippe
    MOVEMENT DISORDERS, 2016, 31 (11) : 1649 - 1657
  • [25] Efficacy and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Glabellar Lines by Age and Race: Subgroup Analysis of the SAKURA Clinical Trials
    Solish, Nowell
    Burgess, Cheryl M.
    Weinkle, Susan H.
    Ablon, Glynis
    Brown, Jessica
    Kooken, Kristie
    Rubio, Roman G.
    AESTHETIC SURGERY JOURNAL, 2023, 43 (02) : 205 - 214
  • [26] XCiDaBLE, a phase IV, observational, prospective trial evaluating incobotulinumtoxin A (XEOMIN®) for cervical dystonia or blepharospasm: preliminary baseline results for subjects with cervical dystonia
    Truong, D.
    Danisi, F.
    Sethi, K.
    Verma, A.
    Pappert, E. J.
    Fernandez, H. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 667 - 667
  • [27] A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia
    Yi Han
    Andrea L. Stevens
    Khashayar Dashtipour
    Robert A. Hauser
    Zoltan Mari
    Journal of Neurology, 2016, 263 : 772 - 780
  • [28] Comparison of the safety and efficacy of botulinum toxin type-A and tizanidine in the treatment of cervical dystonia
    Relja, M
    Telarovic, S
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S327 - S327
  • [29] A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia
    Han, Yi
    Stevens, Andrea L.
    Dashtipour, Khashayar
    Hauser, Robert A.
    Mari, Zoltan
    JOURNAL OF NEUROLOGY, 2016, 263 (04) : 772 - 780
  • [30] Prior Botulinum Toxin Treatment Does Not Impact Efficacy or Safety in Clinical Trials: Analysis of DaxibotulinumtoxinA for Injection in the SAKURA Program
    Cohen, Joel L.
    Green, Lawrence J.
    Beer, Kenneth R.
    Liu, Yan
    Gallagher, Conor J.
    DERMATOLOGIC SURGERY, 2021, 47 (04) : 511 - 515
12345